IWWM-11 2022 | Ongoing trials in WM, where the field is moving, and the growing role of novel agents
Constantine Tam
• 29 Oct 2022
In this video, Constantine Tam, MBBS (Hons), MD, FRACP, FRCPA, Alfred Health, Monash University, Melbourne, Australia, briefly discusses ongoing trials in Waldenström’s macroglobulinemia (WM), and comments on the possibility of moving away from chemotherapy-based regimens in the future. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
